Protagonist Therapeutics (NASDAQ:PTGX) Posts Quarterly Earnings Results, Beats Expectations By $0.39 EPS theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
Protagonist Therapeutics (NASDAQ:PTGX – Get Free Report) posted its earnings results on Tuesday. The company reported $0.44 EPS for the quarter, beating analysts’ consensus estimates of $0.05 by $0.39, MarketWatch Earnings reports. The firm had revenue of $60.00 million for the quarter, compared to analysts’ expectations of $60.00 million. Protagonist Therapeutics Stock Up 3.0 % […]
Protagonist Therapeutics (NASDAQ:PTGX – Get Free Report) released its quarterly earnings results on Tuesday. The company reported $0.44 EPS for the quarter, beating the consensus estimate of $0.05 by $0.39, MarketWatch Earnings reports. The company had revenue of $60.00 million for the quarter, compared to the consensus estimate of $60.00 million. Protagonist Therapeutics Price Performance […]
Profund Advisors LLC grew its holdings in Protagonist Therapeutics, Inc. (NASDAQ:PTGX – Free Report) by 13.4% during the 3rd quarter, according to the company in its most recent disclosure with the SEC. The fund owned 58,716 shares of the company’s stock after purchasing an additional 6,933 shares during the quarter. Profund Advisors LLC’s holdings in […]
Protagonist Therapeutics (NASDAQ:PTGX – Get Free Report) and Mereo BioPharma Group (NASDAQ:MREO – Get Free Report) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their profitability, valuation, earnings, institutional ownership, analyst recommendations, risk and dividends. Insider & Institutional Ownership 98.6% of […]